Loading…
Bon Natural Life Limited is projected to decline to $1.06 by 2027, a -5% move from its current price of $1.11. BON is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.08 | $1.11 | $1.14 | +0.03% |
| Aug 6 | $1.07 | $1.11 | $1.15 | +0.07% |
| Aug 7 | $1.06 | $1.11 | $1.16 | +0.10% |
| Aug 8 | $1.06 | $1.11 | $1.17 | +0.13% |
| Aug 9 | $1.05 | $1.11 | $1.18 | +0.16% |
| Aug 10 | $1.04 | $1.11 | $1.19 | +0.20% |
| Aug 11 | $1.04 | $1.11 | $1.19 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.04 | $1.11 | $1.19 | +0.23% |
| Week 2 | $1.01 | $1.12 | $1.23 | +0.46% |
| Week 3 | $0.9925 | $1.12 | $1.26 | +0.69% |
| Week 4 | $0.9767 | $1.12 | $1.28 | +0.92% |
| Week 5 | $0.9632 | $1.12 | $1.31 | +1.15% |
| Week 6 | $0.9514 | $1.13 | $1.33 | +1.38% |
| Week 7 | $0.9409 | $1.13 | $1.35 | +1.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors and serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi’an, the People’s Republic of China. It is categorized in Basic Materials.
Bon Natural Life Limited (symbol BON) trades as a Basic Materials stock. The current price is $1.12, and the market capitalization stands at $11.39M with a market ranking of 4958. The near-term outlook shows a flat start to the forecast year set, followed by a gradually improving multi-year path in the years ahead.
The stock’s forecast progresses from a neutral near term in 2026 to a more bullish outlook later in the decade and into the 2040s and 2050s.
A major floor 8.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.9% away) — a key level to hold.
The nearest ceiling, 9.9% above — a clean break opens room to run.
A major ceiling 33.3% above — clearing it would confirm fresh momentum.
Key BON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.12 | Sell | $1.12 | Sell |
| MA 10 | $1.14 | Sell | $1.13 | Sell |
| MA 20 | $1.16 | Sell | $1.16 | Sell |
| MA 50 | $1.22 | Sell | $1.21 | Sell |
| MA 100 | $1.27 | Sell | $1.33 | Sell |
| MA 200 | $1.51 | Sell | $3.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.35 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -149.21 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -6.54 | Sell |
| Bollinger %B (20,2) | 0.03 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.31 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 25.55 | Buy |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 1.10 | Buy |
| ADX (14) | 15.55 | Neutral |
| ATR (14) | 0.02 | Info |
In the last 30 days, sentiment is BEARISH with an RSI of 40. The 50-day moving average is $1.24 and the 200-day moving average is $1.54. The stock sits on a support level of $1.12 and faces resistance at $1.48. The 30-day price range spans from $0.9362 to $1.34, indicating limited near-term upside momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.10 | $1.11 | $1.49 | 0% | Neutral | |
| $0.8478 | $1.06 | $1.39 | -5% | Neutral | |
| $0.8337 | $1.07 | $1.46 | -4% | Neutral | |
| $0.8343 | $1.09 | $1.53 | -2% | Neutral | |
| $0.8278 | $1.11 | $1.59 | 0% | Neutral | |
| $0.9683 | $1.32 | $1.93 | +19% | Neutral | |
| $0.9884 | $1.37 | $2.04 | +23% | Bullish | |
| $0.9735 | $1.37 | $2.07 | +23% | Bullish | |
| $0.9991 | $1.42 | $2.19 | +28% | Bullish | |
| $0.9265 | $1.34 | $2.09 | +20% | Bullish | |
| $1.19 | $1.83 | $3.04 | +65% | Bullish | |
| $1.79 | $3.05 | $5.53 | +175% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.10 | $1.11 | $1.37 | +0.00% |
| September 2026 | $0.9729 | $1.15 | $1.39 | +3.47% |
| October 2026 | $0.9623 | $1.14 | $1.40 | -0.44% |
| November 2026 | $0.9871 | $1.18 | $1.46 | +3.13% |
| December 2026 | $0.9979 | $1.20 | $1.49 | +1.59% |
Click any year to see its month-by-month BON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BON is projected to trade between $1.10 and $1.49, averaging $1.11 — a potential gain of 0% from today's $1.11. Price action looks broadly range-bound.
Bon Natural Life Limited's 2027 outlook centres on $1.06, within a $0.8478 to $1.39 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BON could reach as high as $1.46, with a base case around $1.07 and support toward $0.8337 — roughly -4% from $1.11. Price action looks broadly range-bound.
Expect BON to range from $0.8343 to $1.53 through 2029. The $1.09 average target implies a -2% move from current prices. That is up +2% on the projected 2028 average. A consolidation phase looks the most probable path here.
The BON price prediction for 2030 points to an average of $1.11 (low $0.8278, high $1.59) — a potential decline of 0% on today's $1.11. Price action looks broadly range-bound.
In 2031, BON is projected to trade between $0.9683 and $1.93, averaging $1.32 — a potential gain of +19% from today's $1.11. That is up +19% on the projected 2030 average. A consolidation phase looks the most probable path here.
Bon Natural Life Limited's 2032 outlook centres on $1.37, within a $0.9884 to $2.04 range. That is up +4% on the projected 2031 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2033, BON could reach as high as $2.07, with a base case around $1.37 and support toward $0.9735 — roughly +23% from $1.11. Buyers look set to stay in control over this stretch.
Expect BON to range from $0.9991 to $2.19 through 2034. The $1.42 average target implies a +28% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The BON price prediction for 2035 points to an average of $1.34 (low $0.9265, high $2.09) — a potential gain of +20% on today's $1.11. Buyers look set to stay in control over this stretch.
In 2040, BON is projected to trade between $1.19 and $3.04, averaging $1.83 — a potential gain of +65% from today's $1.11. That is up +37% on the projected 2035 average. Momentum favours further upside here.
Bon Natural Life Limited's 2050 outlook centres on $3.05, within a $1.79 to $5.53 range. That is up +67% on the projected 2040 average. That marks a +175% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BON today (≈ 900.900901 BON) could be worth
$2,751.74
+$1,751.74 (+175%) by 2050 · US Dollar
Based on the average projected BON price of $3.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BONwould be worth at today's price.
$1,000 invested in BON on Jul 31, 2025 (≈ 729.927005 BON) would be worth
$810.22
-$189.78 (-19.0%) today · 0.81× · US Dollar
Based on a BON entry price of $1.37 vs. today's $1.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.14 | $973.68 | -2.6% |
| 1 month ago | $1.2 | $925.77 | -7.4% |
| 3 months ago | $1.3 | $853.85 | -14.6% |
| 6 months ago | $1.68 | $660.71 | -33.9% |
| 1 year ago | $1.37 | $810.22 | -19.0% |
| All time (5.0y) ago | $3,300 | $0.34 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BON forecast.
Our base-case forecast reaches $2.20 around 2050.
Implied market cap at $2.20: $13.39M
The multi-year forecast shows a very modest near-term path through 2026–2030, with min prices around $0.8155–$1.12, average prices around $1.10–$1.12, and max prices up to $1.60. The gains are largely flat through 2030, with a slight dip into negative ROI of -1.9% by 2030. Beginning in 2031, the outlook turns gradually more constructive, with 2031 average price $1.33 and 19.1% ROI, followed by continued uplift in 2032 ($1.37, 22.1%), 2033 ($1.37, 22.1%), and 2034 ($1.44, 28.6%).
The forecast remains neutral in 2035 ($1.32 avg, 17.5% ROI). By 2040, the average price lifts to $1.86 with a 66% ROI, and by 2050 the average price reaches $3.02 with a 169.3% ROI, capped by a max of $5.57. These results depict a shift from a cautious near-term stance to stronger longer-term upside, with bullish sentiment reflected in 2032–2034 and again in 2040 and 2050.
Remember, these are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.10 with a min of $0.8155 and a max of $1.60, and a ROI of -1.9%, with sentiment Neutral.
The forecast suggests a mixed near term, with 2026 showing an average of $1.12 and 0% ROI. From 2031 onward, the outlook turns more positive, with 2031 average $1.33 and 19.1% ROI, increasing to 66% by 2040 and 169.3% by 2050.
Yes. By 2040 the max forecast price is $3.13, and by 2050 the max forecast price is $5.57, with 2050 average $3.02 and 169.3% ROI.
For 2035, the min price is $0.9001, the avg price is $1.32, the max price is $2.09, and the ROI is 17.5% with neutral sentiment.
Bon Natural Life Limited Community Discussion
0Share your Bon Natural Life Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.